Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Oncolytics Biotech Inc T.ONC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer.
Price: $0.93 | Change: +$0.08 | %Change: +9.41%
Volume: 683,966 | Day High/Low: 0.98/0.87 | 52 Week High/Low: 1.82/0.445
View modes: 
0 stars

Orphan Status a two-edged sword

Oncolytics Biotech has a very promising product, and from what I can tell, are still very much in the running if thier funding can hold out until they finish phase III testing.   It seems to me that...read more
5 stars

Oncolytics's Reolysin receives orphan drug designation

It is totally beyond me why the s/p is trading at these incredibly low level....Something must give eventually on the upside.....GLTA   Oncolytics's Reolysin receives orphan drug designation...read more
0 stars

RE:FDA ok for Glioma

Results for All Designations Return to Orphan Designation Search Page Row Num Generic Name Designation Date Orphan Designation 1 pelareorep 02-24-2015 Treatment of fallopian tube cancer ...read more
5 stars

FDA ok for Glioma

According to the FDA web site ONC has been granted orphan status for Pelareorep (reolysin) for the treatment of glioma. Another positive step!  rate and reply
0 stars

50 cent days

Hope we get those + $0.50 days back.  :D This stock trades crazy like.  :O  rate and reply
5 stars

EMA approval?

Several years ago I posted the opinion that the EMA would grant approval before the FDA. With the positive results from Matt Coffey's presentation and the recent news that the EMA was considering a...read more
3 stars

Be Polite: Distance Your Organization

I’m pleased to see that Brad is speaking at the Needham Conference tomorrow. If Needham joined RBC and Cowen to become the third investor health conference to deny Brad the opportunity to peddle...read more
0 stars

Another NR - ODD - Gastric Cancer

http://www.newswire.ca/en/story/1513321/oncolytics-biotech-inc-announces-filing-for-orphan-drug-designation-with-the-u-s-fda-for-gastric-cancer  rate and reply
0 stars

Corporate Presentation April 2015

http://www.oncolyticsbiotech.com/files/doc_presentations/2015/Corporate-Presentation-(April-3-2015)_v001_p09z0i.pdf  rate and reply
0 stars

RE:delist

ONCY can apply for an extension on its NASDAQ listing period, I believe.  rate and reply
0 stars

RE:delist

Only on the Nasdaq. I think BT will have something to to release before then, I hope.  rate and reply
0 stars

delist

Apr27, this will be delisted, right?  rate and reply
0 stars

PREPARE FOR LIFTOFF........ ;-)

  rate and reply
0 stars

RE:Not a stock to buy into !!!!!!

You bothered to hold this whole time then sold right before their first of four corporate presentations across Canada?  rate and reply
0 stars

RE:Not a stock to buy into !!!!!!

whatever....spellcheck dude.  rate and reply
0 stars

Not a stock to buy into !!!!!!

sold with loss,  some stocks we buy with  BNN  guest  recomendation is  fulish  we may go gray as the guest on BNN if we fallow them. always watch trading patern of a stock  before you buy.  rate and reply
5 stars

Added more ONC today

Let's get back to the $2 range !!! Keep the positive news coming.  rate and reply
1 star

RE:European Agency (“EMA”) granted drug Cancers treatment

What do you mean? It is traded in the u.s. market. Stock symbol ONCY. Recieved the same designations from the FDA earlier this year.  rate and reply
5 stars

Potential 1000%+ Cancers drug approval

this could be the bigest run you and me have seen. read EU approval  rate and reply
3 stars

European Agency (“EMA”) granted drug Cancers treatment

In US market that would be at least $10 back+ stock Oncolytics Biotech® (TSX: ONC, Stock Forum) made serious headway in advancing the development of REOLYSIN® when the company announced today that...read more